MedTrace Logo

Effect of Omega-3 Index on Cellular Metabolism and Quality of Life

NCT03159507 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2019-04-04

No results posted yet for this study

Summary

Determine whether personal optimization of the Omega-3 index improves cellular metabolism and quality of life (according to the SF-36 form).

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

MAG-EPA

Based on the result of the participant's Omega-3 index obtained from the blood sampling of visit 1, the daily dose of MAG-EPA will be adjusted to obtain an Omega-3 Index of 8.

Sponsors & Collaborators

  • Université du Québec à Rimouski

    collaborator UNKNOWN

  • SCF Pharma

    lead INDUSTRY

Principal Investigators

  • Anne-Julie Landry, MSc · SCF Pharma

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-02
Primary Completion
2019-03-14
Completion
2019-03-14

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03159507 on ClinicalTrials.gov